 |
|
Mayo Clinic clarifies diagnosis for serious blood vessel disease of brain and spinal cord
October 19, 2007ROCHESTER, Minn. -- Mayo Clinic has clarified the methods of diagnosis and optimal management of a rare and little-understood blood vessel disease of the brain and spinal cord that often leads to stroke or death. Primary central nervous system vasculitis (PCNSV) can best be identified through a combination of diagnostic techniques consisting of angiography (imaging the cerebral arteries), brain biopsy and other laboratory studies.
This disease is often suspected based on a combination of symptoms, along with the initial results of brain imaging with CT or MRI. The Mayo study clarifies the usefulness of the evaluation techniques and suggests that a combined diagnostic approach is needed. Primary central nervous system vasculitis is difficult to diagnose because it is not a single disease, but a variable syndrome that appears to consist of several distinct subsets of different diseases that can mimic other less-serious conditions, thus eluding treatment. Frequent symptoms are headache, altered cognition, or stroke, and visual symptoms. Recognizing the symptoms and understanding the role of evaluation techniques, may lead to earlier identification and treatment of patients.
This Mayo Clinic analysis of 101 patients seen with primary central nervous system vasculitis over 21 years represents one of the largest reported groups of patients with this disorder. The Mayo Clinic research report on improved understanding of PCNSV appears in the current edition of Annals of Neurology (http://www3.interscience.wiley.com/cgi-bin/jissue/78504407).
Significance of the Mayo Clinic Research
Primary central nervous system vasculitis has two traits that make it difficult, yet important, to study:
* It is rare and poorly understood. Few medical centers see enough patients with confirmed diagnoses to collect enough data to analyze.
* It carries a high potential for serious complications, even death. A blood vessel that malfunctions may disrupt blood supply and oxygen to the brain or spinal cord, leading to a stroke.
While angiography has been the preferred diagnostic technique because it is less invasive and carries fewer risks than brain biopsy, no studies had determined its accuracy or established angiographic criteria for the diagnosis. "Progress in understanding PCNSV has been slow because its occurrence is infrequent and its identification is difficult," explains Robert D. Brown Jr., M.D., chair of the Mayo Clinic Department of Neurology, and the lead investigator. "Our study begins to answer some essential questions that can clarify diagnosis and hopefully lead to earlier, and successful, management."
Symptoms and Treatment
Patients with PCNVS in the Mayo Clinic study had the following symptoms: headache was the most common, followed by changes in ability to think or remember (cognitive impairment); weakness on one side of the body; and difficulty speaking (aphasia). Of the 101 patients, 97 were prescribed initial treatment consisting of oral or intravenous doses of the steroid drug prednisone; some received oral or intravenous doses of the chemotherapy drug cyclophosphamide. Most showed favorable responses. "This encouraging finding emphasizes the need for early diagnosis and initiation of therapy that may help avoid serious and irreversible complications," says Dr. Brown.
Key Findings
Some the study's main findings:
* Angiography imaging of blood vessels appears to complement brain biopsy in determining diagnosis.
* PCNSV is not a single disease, but a variable syndrome that appears to consist of several distinct subsets of different diseases.
* Though treatment is available and most patients responded to therapy, relapse was common, occurring in 25 percent of patients studied.
* Death and disability rates among patients were highest in those who had a defined brain dysfunction, such as cognitive impairment, stroke and disease of the large blood vessels on angiography.
* The annual incidence rate of primary central nervous system vasculitis was 2.4 cases per 1 million people.
Collaboration and Support
Other members of the Mayo Clinic research team include Carlo Salvarani, M.D.; Kenneth Calamia, M.D.; Teresa Christianson; Stephen Weigand; Dylan Miller, M.D.; Caterina Giannini, M.D.; James Meschia, M.D.; John Huston III, M.D.; and Gene Hunder, M.D. Their work was supported with grants from Mayo Foundation for Medical Education and Research.
Mayo Clinic
Significance of the Mayo Clinic Research
Primary central nervous system vasculitis has two traits that make it difficult, yet important, to study:
* It is rare and poorly understood. Few medical centers see enough patients with confirmed diagnoses to collect enough data to analyze.
* It carries a high potential for serious complications, even death. A blood vessel that malfunctions may disrupt blood supply and oxygen to the brain or spinal cord, leading to a stroke.
While angiography has been the preferred diagnostic technique because it is less invasive and carries fewer risks than brain biopsy, no studies had determined its accuracy or established angiographic criteria for the diagnosis. "Progress in understanding PCNSV has been slow because its occurrence is infrequent and its identification is difficult," explains Robert D. Brown Jr., M.D., chair of the Mayo Clinic Department of Neurology, and the lead investigator. "Our study begins to answer some essential questions that can clarify diagnosis and hopefully lead to earlier, and successful, management."
Symptoms and Treatment
Patients with PCNVS in the Mayo Clinic study had the following symptoms: headache was the most common, followed by changes in ability to think or remember (cognitive impairment); weakness on one side of the body; and difficulty speaking (aphasia). Of the 101 patients, 97 were prescribed initial treatment consisting of oral or intravenous doses of the steroid drug prednisone; some received oral or intravenous doses of the chemotherapy drug cyclophosphamide. Most showed favorable responses. "This encouraging finding emphasizes the need for early diagnosis and initiation of therapy that may help avoid serious and irreversible complications," says Dr. Brown.
Key Findings
Some the study's main findings:
* Angiography imaging of blood vessels appears to complement brain biopsy in determining diagnosis.
* PCNSV is not a single disease, but a variable syndrome that appears to consist of several distinct subsets of different diseases.
* Though treatment is available and most patients responded to therapy, relapse was common, occurring in 25 percent of patients studied.
* Death and disability rates among patients were highest in those who had a defined brain dysfunction, such as cognitive impairment, stroke and disease of the large blood vessels on angiography.
* The annual incidence rate of primary central nervous system vasculitis was 2.4 cases per 1 million people.
Collaboration and Support
Other members of the Mayo Clinic research team include Carlo Salvarani, M.D.; Kenneth Calamia, M.D.; Teresa Christianson; Stephen Weigand; Dylan Miller, M.D.; Caterina Giannini, M.D.; James Meschia, M.D.; John Huston III, M.D.; and Gene Hunder, M.D. Their work was supported with grants from Mayo Foundation for Medical Education and Research.
Mayo Clinic
Blood Vessel Disease Current Events and Blood Vessel Disease News RSSGene is likely cause of stroke-inducing vascular malformations
UCSF scientists have discovered that a gene controlling whether blood vessels differentiate into arteries or veins during embryonic development is linked to a vascular disorder in the brain that causes stroke.
Small birth size linked to changes in the cardiovascular system that predispose to later disease
Researchers have found the first evidence that smaller size at birth is associated with specific alterations in the functioning of the heart and circulation in children and that these changes differ between boys and girls.
Researchers study potential health benefits of natural chemicals in muscadine grape seeds
Could some of the natural chemicals found in plants be powerful enough to improve cardiovascular health" Researchers at Wake Forest University Baptist Medical Center are conducting the first-ever clinical study to evaluate the potential cardiovascular health effects of Nature's Pearl Muscadine Grape Seed Supplement.
DNA sequence of Rhesus macaque has evolutionary, medical implications
The completed DNA sequence of the rhesus macaque - an Old World monkey - has advanced understanding of primate evolution and will enhance medical research in neuroscience, behavioral biology, reproductive physiology, endocrinology, heart and blood vessel disease and immunodeficiency.
Diabetes may be associated with increased risk of mild cognitive impairment
Individuals with diabetes may have a higher risk of developing mild cognitive impairment, a condition that involves difficulties with thinking and learning and may be an intermediate step toward Alzheimer's disease, according to a report in the April issue of Archives of Neurology, one of the JAMA/Archives journals.
First step in developing heart hormone-based pill to control high blood pressure
In an era of increasing death and illness from heart and blood vessel disease — which also can impair kidney function — Mayo Clinic researchers have designed two promising new cardiovascular treatment approaches.
Natural pine bark extract relieves muscle cramp and pain in athletes and diabetics
A study published in this month's issue of Angiology shows that supplementation with the pine bark extract Pycnogenol® (pic-noj-en-all) improves blood flow to the muscles which speeds recovery after physical exercise.
Nearly half of people who need cholesterol treatment don't get it
Even though treatment for cholesterol disorders can reduce the risk of heart and blood vessel disease by about 30 percent over five years, many at-risk people aren't getting adequate treatment.
Nocturnal dialysis improves heart disease in patients with end-stage kidney failure
Night-time hemodialysis patients may have a greater capacity to repair their hearts and blood vessels compared to those on conventional dialysis three times a week.
Aortic aneurysm associated with decreased incidence of atherosclerosis
Oddly enough, having an aneurysm in the ascending aorta is significantly associated with decreased incidence of atherosclerosis, according to a study by Yale School of Medicine researchers published this month in Chest.
More Blood Vessel Disease Current Events and Blood Vessel Disease News Articles
| © 2009 BrightSurf.com |